Clinical Trial Update: ATS 3f Enable(tm) Aortic Bioprosthesis, Model 6000 [NA]

View source ↗

Summary

A completed clinical trial evaluating the ATS 3f Enable Aortic Bioprosthesis, Model 6000, sponsored by Medtronic Cardiovascular. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• ATS 3f Enable Aortic Bioprosthesis, Model 6000

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Heart Valve Diseases | NA | Status: COMPLETED | Results posted: 2016-12-05